According to monitoring by PolyBeats, Anthropic completed its IPO pricing at $83 per share, with a first-day gain of about 17%, a market cap of approximately $1.27T, and a share price of $97.17.
On the prediction market Polymarket, the "Yes" probability for "Will Anthropic's valuation rise to $1.75T this year?" is 31%.
TheReturnOfDarthMaul has 10 open positions in the "Will Anthropic's valuation rise/fall to ___ this year" event, with a total cost of about $399k. His bets are roughly: the valuation high will exceed $2T, but will not reach $2.25T.
TheReturnOfDarthMaul has a 78% win rate across 50 markets traded in the financial sector, with PnL +$66.2k and ROI +12.7%. In total, he has participated in 1,169 market trades, with a win rate of 62.3%, PnL +$1.6M, and ROI +9.8%.
On the upside strikes, he bought "Yes" at $2T and $1.75T, both of which are losing positions; he also bought "No" at $2.25T, $2.5T, $3T, $4T, and $5T. These "No" positions total about $311k in cost and are his main positions in this event, currently showing a small unrealized gain. On the downside, he bought "No" at $800B, $700B, and $600B, totaling about $25.5k, believing the valuation will not fall back to those levels.
Most of the first batch of covering institutions are bullish. Needham (Scott Berg) gave a Buy rating and a $150 price target, about 81% above the $83 issue price, and expects FY27 revenue growth of more than 150% and operating margin of more than 35%; Citizens JMP's Patrick Walravens gave a Buy rating and a $125 price target; New Street Research's Pierre Ferragu gave a Buy rating and a $105 price target, calling it a "generational IPO." William Blair (Arjun Bhatia) gave an Outperform rating without a price target, saying that a 9x price-to-sales ratio based on 2027 revenue estimates is "reasonable," and that if it were given 17 to 20x, the corresponding share price would be $130 to $150.
